Fig. 3
From: PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia
The comparisons of time (days) of obtaining complete remission and complete remission rate between low and high PIM-1 expression. Comparisons of the time (days) of obtaining complete remission between low and high expression in patients with AML (a). Comparisons of complete remission rate between low and high expression in patients with AML after induction therapy (b). P value is calculated according to student’s t test (a). P value is calculated according to Chi square test (b)